Veru-111 Advice
He has castration-resistant prostate cancer with progression despite abiraterone, enzalutamide, and docetaxel chemotherapy. About 4 months ago, he began treatment with radium-223, and has received 5 of 6 infusions thus far. His oncologist does not feel he needs to complete the 6th.
He has castration-resistant prostate cancer with progression despite abiraterone, enzalutamide, and docetaxel chemotherapy. About 4 months ago, he began treatment with radium-223, and has received 5 of 6 infusions thus far. His oncologist does not feel he needs to complete the 6th.